(Q48702678)

14 February 2018

title

Present at the beginning: a personal reminiscence on the history of teriparatide. (English)

1 reference

14 February 2018

author name string

R Marcus

series ordinal

1

1 reference

14 February 2018

language of work or name

English

0 references

publication date

31 March 2011

1 reference

14 February 2018

Osteoporosis International

published in

1 reference

14 February 2018

volume

22

1 reference

14 February 2018

issue

8

1 reference

14 February 2018

page(s)

2241-2248

1 reference

14 February 2018

https://scigraph.springernature.com/pub.10.1007/s00198-011-1598-x

exact match

0 references

cites work

Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

STUDIES OF CALCIUM AND PHOSPHORUS METABOLISM : V. A STUDY OF THE BONE TRABECULAE AS A READILY AVAILABLE RESERVE SUPPLY OF CALCIUM

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

ON THE STIMULATION OF NEW BONE-FORMATION WITH PARATHYROID EXTRACT AND IRRADIATED ERGOSTEROL

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

The partial purification of parathyroid hormone by means of ultrafiltration and displacement chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

Activation of skeletal adenyl cyclase by parathyroid hormone in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

Parathyroid function and the renal excretion of 3'5'-adenylic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

Pseudohypoparathyroidism: defective excretion of 3',5'-AMP in response to parathyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

Bovine parathyroid hormone: amino acid sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

Human Parathyroid Hormone: Amino-Acid Sequence of the Amino-Terminal Residues 1-34

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

The Amino-Acid Sequence of the Amino-Terminal 37 Residues of Human Parathyroid Hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

Reinvestigation of the amino-terminal sequence of human parathyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

Nucleotide sequence of the human parathyroid hormone gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

Bovine Parathyroid Hormone: Minimum Chain Length of Synthetic Peptide Required for Biological Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

Dexamethasone-treated ROS 17/2.8 rat osteosarcoma cells are responsive to human carboxylterminal parathyroid hormone peptide hPTH (53-84): stimulation of alkaline phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

Receptors specific for the carboxyl-terminal region of parathyroid hormone on bone-derived cells: determinants of ligand binding and bioactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

Receptors for the carboxyl-terminal region of pth(1-84) are highly expressed in osteocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

Solid-Phase Synthesis of the Biologically Active N-Terminal 1—34 Peptide of Human Parathyroid Hormone

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

21 January 2018

12 December 2020

The Induction of Osteopetrotic Changes in Hypophysectomized, Thyroparathyroidectomized, and Intact Rats of Various Ages

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

Molecular and cellular mechanisms of the anabolic effect of intermittent PTH

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

Effects of parathyroid hormone on Wnt signaling pathway in bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

SOST is a target gene for PTH in bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

Control of the SOST bone enhancer by PTH using MEF2 transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

Bone neoplasms in F344 rats given teriparatide [rhPTH(1-34)] are dependent on duration of treatment and dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

Defining a noncarcinogenic dose of recombinant human parathyroid hormone 1-84 in a 2-year study in Fischer 344 rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

On the interpretation of rat carcinogenicity studies for human PTH(1-34) and human PTH(1-84).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

Teriparatide or alendronate in glucocorticoid-induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

Chronic response of dogs to parathyroid hormone infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1598-X

Osteosarcoma and teriparatide?

21 January 2018

1 reference

12 December 2020

Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety

1 reference

12 December 2020

Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells

1 reference

12 December 2020

Isolation of parathyroid hormone after extraction with phenol

1 reference

12 December 2020

The amino acid sequence of bovine parathyroid hormone I

1 reference

12 December 2020

Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis

1 reference

12 December 2020

The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats

1 reference

12 December 2020

Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures

1 reference

12 December 2020

Parathyroid hormone-sensitive adenyl cyclase in isolated renal tubules

1 reference

12 December 2020

Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study

1 reference

12 December 2020

Teriparatide and osseous regeneration in the oral cavity

1 reference

12 December 2020

Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial

1 reference

12 December 2020

The amino acid sequence of porcine parathyroid hormone

1 reference

12 December 2020

Anabolic effect of parathyroid hormone on bone in the rat

1 reference

12 December 2020

The effect of parathyroid hormone on the concentration of adenosine 3',5'-monophosphate in skeletal tissue in vitro

1 reference

12 December 2020

Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial

1 reference

12 December 2020

Skeletal disease in primary hyperparathyroidism

1 reference

12 December 2020

Bioassay of parathyroid hormone in vitro with a stable preparation of adenyl cyclase from rat kidney

1 reference

12 December 2020

A biologically active amino-terminal fragment of bovine parathyroid hormone prepared by dilute acid hydrolysis

1 reference

12 December 2020

10.1007/S00198-011-1598-X

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018